Insider Transactions in Q1 2025 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2025
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
828
+0.03%
|
-
|
|
Mar 31
2025
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
828
+6.51%
|
-
|
|
Mar 31
2025
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
1,471
+6.62%
|
-
|
|
Mar 31
2025
|
Elizabeth H.Z. Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
694
+9.64%
|
-
|
|
Mar 31
2025
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
1,284
+2.37%
|
-
|
|
Mar 31
2025
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
828
+0.9%
|
-
|
|
Mar 31
2025
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
1,906
+0.15%
|
-
|
|
Mar 14
2025
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,701
-5.56%
|
$1,701
$1.23 P/Share
|
|
Mar 14
2025
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
4,512
-5.78%
|
$4,512
$1.23 P/Share
|
|
Mar 14
2025
|
Mary Beth Harler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,329
-2.11%
|
$7,329
$1.23 P/Share
|
|
Mar 14
2025
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,329
-3.91%
|
$7,329
$1.23 P/Share
|
|
Jan 15
2025
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,122
-3.54%
|
$1,122
$1.7 P/Share
|